Antu Eapan Thomas
Stock Analyst at Geojit Research
(1.02)
# 3,658
Out of 4,408 analysts
43
Total ratings
40.5%
Success rate
-2.7%
Average return
Main Sectors:
Stocks Rated by Antu Eapan Thomas
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: FORTIS Fortis Healthcare Limited | Reiterated: Buy | ₹1,150 | $980.15 | +17.33% | 1 | Jun 15, 2026 | |
| NSE: PVRINOX PVR INOX Limited | Maintained: Buy | ₹1,065 → ₹1,189 | $943.80 | +25.98% | 2 | Jun 5, 2026 | |
| NSE: RAINBOW Rainbow Children's Medicare Limited | Initiated Coverage: Buy | ₹1,679 | $1,418.60 | +18.36% | 1 | May 27, 2026 | |
| NSE: SBICARD SBI Cards and Payment Services Limited | Maintained: Buy | ₹950.00 → ₹698.00 | $600.90 | +16.16% | 2 | May 18, 2026 | |
| NSE: LICI Life Insurance Corporation of India | Reiterated: Buy | ₹544.00 → ₹467.00 | $405.70 | +15.11% | 3 | Mar 18, 2026 | |
| NSE: NBCC NBCC (India) Limited | Rated: Hold | n/a | $107.36 | - | 1 | Mar 17, 2026 | |
| NSE: GODREJPROP Godrej Properties Limited | Maintained: Buy | ₹2,096 | $1,766.20 | +18.67% | 1 | Feb 26, 2026 | |
| NSE: AMBER Amber Enterprises India Limited | Initiated Coverage: Buy | ₹9,156 | $7,620.00 | +20.16% | 1 | Feb 23, 2026 | |
| NSE: HCG HealthCare Global Enterprises Limited | Upgraded: Buy | ₹628.00 → ₹724.00 | $627.35 | +15.41% | 2 | Feb 19, 2026 | |
| NSE: KIMS Krishna Institute of Medical Sciences Limited | Maintained: Buy | ₹780.00 | $769.85 | +1.32% | 1 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,180 | $1,028.90 | +14.69% | 1 | Feb 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹568.00 → ₹791.00 | $302.50 | +161.49% | 3 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹686.00 | $492.80 | +39.20% | 1 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹4,409 → ₹4,560 | $4,169.80 | +9.36% | 2 | Feb 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹857.00 → ₹828.00 | $581.20 | +42.46% | 4 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,244 → ₹2,080 | $1,734.10 | +19.95% | 2 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹312.00 → ₹439.00 | $416.05 | +5.52% | 2 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | ₹1,076 | $1,020.85 | +5.40% | 1 | Jan 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,085 | $1,085.30 | -0.03% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,254 | $1,759.50 | +28.10% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,790 → ₹1,613 | $1,425.60 | +13.15% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,015 | $864.40 | +17.42% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,820 | $1,374.70 | +32.39% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,791 → ₹1,247 | $575.20 | +116.79% | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹3,691 | $2,162.00 | +70.72% | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹386.00 | $206.26 | n/a | 1 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹2,770 | $708.00 | n/a | 1 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹326.00 | $310.60 | n/a | 1 | Dec 10, 2024 |
Fortis Healthcare Limited
Jun 15, 2026
Reiterated: Buy
Price Target: ₹1,150
Current: $980.15
Upside: +17.33%
PVR INOX Limited
Jun 5, 2026
Maintained: Buy
Price Target: ₹1,065 → ₹1,189
Current: $943.80
Upside: +25.98%
Rainbow Children's Medicare Limited
May 27, 2026
Initiated Coverage: Buy
Price Target: ₹1,679
Current: $1,418.60
Upside: +18.36%
SBI Cards and Payment Services Limited
May 18, 2026
Maintained: Buy
Price Target: ₹950.00 → ₹698.00
Current: $600.90
Upside: +16.16%
Life Insurance Corporation of India
Mar 18, 2026
Reiterated: Buy
Price Target: ₹544.00 → ₹467.00
Current: $405.70
Upside: +15.11%
NBCC (India) Limited
Mar 17, 2026
Rated: Hold
Price Target: n/a
Current: $107.36
Upside: -
Godrej Properties Limited
Feb 26, 2026
Maintained: Buy
Price Target: ₹2,096
Current: $1,766.20
Upside: +18.67%
Amber Enterprises India Limited
Feb 23, 2026
Initiated Coverage: Buy
Price Target: ₹9,156
Current: $7,620.00
Upside: +20.16%
HealthCare Global Enterprises Limited
Feb 19, 2026
Upgraded: Buy
Price Target: ₹628.00 → ₹724.00
Current: $627.35
Upside: +15.41%
Krishna Institute of Medical Sciences Limited
Feb 19, 2026
Maintained: Buy
Price Target: ₹780.00
Current: $769.85
Upside: +1.32%
Feb 16, 2026
Upgraded: Buy
Price Target: ₹1,180
Current: $1,028.90
Upside: +14.69%
Feb 11, 2026
Reiterated: Buy
Price Target: ₹568.00 → ₹791.00
Current: $302.50
Upside: +161.49%
Feb 10, 2026
Maintained: Buy
Price Target: ₹686.00
Current: $492.80
Upside: +39.20%
Feb 1, 2026
Reiterated: Buy
Price Target: ₹4,409 → ₹4,560
Current: $4,169.80
Upside: +9.36%
Jan 29, 2026
Reiterated: Buy
Price Target: ₹857.00 → ₹828.00
Current: $581.20
Upside: +42.46%
Jan 28, 2026
Maintained: Buy
Price Target: ₹2,244 → ₹2,080
Current: $1,734.10
Upside: +19.95%
Jan 2, 2026
Upgraded: Buy
Price Target: ₹312.00 → ₹439.00
Current: $416.05
Upside: +5.52%
Jan 1, 2026
Downgraded: Hold
Price Target: ₹1,076
Current: $1,020.85
Upside: +5.40%
Nov 11, 2025
Upgraded: Buy
Price Target: ₹1,085
Current: $1,085.30
Upside: -0.03%
Nov 10, 2025
Maintained: Buy
Price Target: ₹2,254
Current: $1,759.50
Upside: +28.10%
Nov 7, 2025
Maintained: Buy
Price Target: ₹1,790 → ₹1,613
Current: $1,425.60
Upside: +13.15%
Oct 31, 2025
Maintained: Buy
Price Target: ₹1,015
Current: $864.40
Upside: +17.42%
Oct 31, 2025
Upgraded: Buy
Price Target: ₹1,820
Current: $1,374.70
Upside: +32.39%
Oct 8, 2025
Reiterated: Buy
Price Target: ₹1,791 → ₹1,247
Current: $575.20
Upside: +116.79%
Jul 15, 2025
Reiterated: Buy
Price Target: ₹3,691
Current: $2,162.00
Upside: +70.72%
Jun 9, 2025
Maintained: Buy
Price Target: ₹386.00
Current: $206.26
Upside: n/a
Apr 2, 2025
Maintained: Hold
Price Target: ₹2,770
Current: $708.00
Upside: n/a
Dec 10, 2024
Maintained: Hold
Price Target: ₹326.00
Current: $310.60
Upside: n/a